IL57343A - Pharmaceutical compositions comprising aryl hydantoins,certain such novel compounds and their preparation - Google Patents

Pharmaceutical compositions comprising aryl hydantoins,certain such novel compounds and their preparation

Info

Publication number
IL57343A
IL57343A IL57343A IL5734379A IL57343A IL 57343 A IL57343 A IL 57343A IL 57343 A IL57343 A IL 57343A IL 5734379 A IL5734379 A IL 5734379A IL 57343 A IL57343 A IL 57343A
Authority
IL
Israel
Prior art keywords
preparation
certain
pharmaceutical compositions
novel compounds
hydantoins
Prior art date
Application number
IL57343A
Other languages
English (en)
Other versions
IL57343A0 (en
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of IL57343A0 publication Critical patent/IL57343A0/xx
Publication of IL57343A publication Critical patent/IL57343A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL57343A 1978-05-23 1979-05-21 Pharmaceutical compositions comprising aryl hydantoins,certain such novel compounds and their preparation IL57343A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (2)

Publication Number Publication Date
IL57343A0 IL57343A0 (en) 1979-09-30
IL57343A true IL57343A (en) 1982-09-30

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57343A IL57343A (en) 1978-05-23 1979-05-21 Pharmaceutical compositions comprising aryl hydantoins,certain such novel compounds and their preparation

Country Status (31)

Country Link
US (2) US4241073A (fr)
EP (1) EP0005647B1 (fr)
JP (1) JPS54160373A (fr)
KR (1) KR830000635B1 (fr)
AR (2) AR225143A1 (fr)
AT (1) AT366034B (fr)
AU (1) AU530968B2 (fr)
BE (1) BE876435A (fr)
BG (2) BG31799A3 (fr)
CA (1) CA1120481A (fr)
CH (2) CH639650A5 (fr)
CS (2) CS208653B2 (fr)
DD (1) DD143769A5 (fr)
DE (1) DE2963061D1 (fr)
DK (1) DK207579A (fr)
ES (1) ES480850A1 (fr)
FI (1) FI791614A (fr)
FR (1) FR2426681A1 (fr)
GB (1) GB1601310A (fr)
GR (1) GR68363B (fr)
HU (1) HU184648B (fr)
IL (1) IL57343A (fr)
LU (1) LU81300A1 (fr)
MX (1) MX5604E (fr)
NZ (1) NZ190512A (fr)
PL (2) PL119612B1 (fr)
PT (1) PT69648A (fr)
RO (2) RO79703A (fr)
SU (2) SU873878A3 (fr)
YU (1) YU120179A (fr)
ZA (1) ZA792501B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
HU204047B (en) * 1987-01-31 1991-11-28 Sandoz Ag Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0526598B1 (fr) * 1990-04-27 1996-12-18 Orion-Yhtymà„ Oy Nouveaux derives de pyrocatechine a activite pharmacologique
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
AU2351795A (en) * 1994-04-28 1995-11-29 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
CA2468846A1 (fr) * 2001-11-30 2003-06-12 Eli Lilly And Company Agonistes du recepteur active de proliferation du peroxisome
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
ES2542153T3 (es) * 2007-05-30 2015-07-31 F. Hoffmann-La Roche Ag Inhibidores no nucleósidos de la transcriptasa inversa
JP2011502998A (ja) * 2007-11-01 2011-01-27 ザ ユーエイビー リサーチ ファウンデイション ウイルス感染の治療および予防
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
US3365296A (en) * 1964-05-18 1968-01-23 Gen Aniline & Film Corp Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (fr) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
EP0005647A1 (fr) 1979-11-28
RO76807A (fr) 1981-04-26
US4241073A (en) 1980-12-23
SU873878A3 (ru) 1981-10-15
ES480850A1 (es) 1980-02-01
YU120179A (en) 1983-02-28
PL222701A1 (fr) 1980-12-15
KR830000635B1 (ko) 1983-03-23
NZ190512A (en) 1984-10-19
CA1120481A (fr) 1982-03-23
CH643546A5 (fr) 1984-06-15
AU4728979A (en) 1979-11-29
AU530968B2 (en) 1983-08-04
EP0005647B1 (fr) 1982-06-09
GB1601310A (en) 1981-10-28
ATA373379A (de) 1981-07-15
FR2426681B1 (fr) 1983-08-12
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
IL57343A0 (en) 1979-09-30
SU988190A3 (ru) 1983-01-07
AT366034B (de) 1982-03-10
DK207579A (da) 1979-11-24
DE2963061D1 (en) 1982-07-29
ZA792501B (en) 1980-05-28
BG32115A4 (en) 1982-05-14
AR224186A1 (es) 1981-10-30
US4293563A (en) 1981-10-06
FR2426681A1 (fr) 1979-12-21
BG31799A3 (en) 1982-03-15
CS208654B2 (en) 1981-09-15
PT69648A (en) 1979-06-01
PL215773A1 (fr) 1980-07-14
PL119612B1 (en) 1982-01-30
MX5604E (es) 1983-11-07
BE876435A (fr) 1979-11-21
FI791614A (fi) 1979-11-24
CH639650A5 (fr) 1983-11-30
GR68363B (fr) 1981-12-23
AR225143A1 (es) 1982-02-26
HU184648B (en) 1984-09-28
LU81300A1 (fr) 1980-12-16
RO79703A (fr) 1982-08-17
JPS54160373A (en) 1979-12-19
PL125075B1 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
IL57343A (en) Pharmaceutical compositions comprising aryl hydantoins,certain such novel compounds and their preparation
IL56556A (en) Pharmaceutical compositions comprising imidazole derivatives and certain such novel compounds
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
DE2964135D1 (en) Pharmaceutical compositions containing urea
IL58579A (en) Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL57040A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
DE2862404D1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL58681A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
GB2034587B (en) Pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
DE2966444D1 (en) Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
IL57854A0 (en) Substituted 2-phenylamino-imidazoline-(2)-derivatives,their preparation and pharmaceutical compositions containing them
IL56075A0 (en) Novel arylaminoimidazoline derivatives,their preparation and pharmaceutical compositions containing them
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them